Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL20510360

Cc1cnccc1N1CC2(CNC2)C1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TMEM97 Q5BJF2 1/20 0.39
▸ OPRM1 P35372 1/20 0.36
▸ OPRL1 P41146 1/20 0.36
▸ C1S P09871 1/20 0.35
▸ CYP2C9 P11712 6/20 0.34
▸ SLC2A1 P11166 2/20 0.34
▸ HRH4 Q9H3N8 1/20 0.34
▸ TSHR P16473 2/20 0.33
▸ GPR6 P46095 1/20 0.33
▸ CYP2C19 P33261 3/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ USP2 O75604 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ IRAK4 Q9NWZ3 1/20 0.33
▸ CHRM1 P11229 1/20 0.32
▸ RBP4 P02753 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21667809 0.87 TMEM97 (0.43) TMEM97OPRM1OPRL1CYP2C9TSHR
Trifluoroacetic Acid SCHEMBL20510269 0.79 CYP2C9 (0.51) CYP2C9TSHRCYP2C19HSD17B10CYP3A4
Trifluoroacetic Acid SCHEMBL20510794 0.78 CHRNA7 (0.48) TMEM97CHRM1
Trifluoroacetic Acid SCHEMBL30059747 0.78 DPP4 (0.48) CYP2C9TSHRCYP2C19ALDH1A1CYP2D6
Trifluoroacetic Acid SCHEMBL21048277 0.78 DPP4 (0.48) CYP2C9TSHRCYP2C19ALDH1A1CYP2D6
Trifluoroacetic Acid SCHEMBL20510487 0.73 MAPK1 (0.39) TMEM97CYP2C9SLC2A1HRH4TSHR
Trifluoroacetic Acid SCHEMBL20798079 0.72 HSD17B10 (0.50) CYP2C9TSHRCYP2C19HSD17B10CYP3A4
Trifluoroacetic Acid SCHEMBL15572196 0.72 HSD17B10 (0.50) CYP2C9TSHRCYP2C19HSD17B10CYP3A4
Trifluoroacetic Acid SCHEMBL20510933 0.72 RBP4 (0.39) TMEM97C1SCYP2C9HRH4TSHR
Trifluoroacetic Acid SCHEMBL20510323 0.72 CYP2C19 (0.50) CYP2C9TSHRCYP2C19HSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577251-B2 Modulators of the sigma-2 receptor and their method of use Temple University—Of the Commonwealth System of Higher Education (US) 2026-03-17 — — US disclosed
EP-3600290-B1 NOVEL MODULATORS OF THE SIGMA-2 RECEPTOR AND THEIR METHOD OF USE UNIV TEMPLE (US) 2025-06-04 — — EP disclosed
US-20240300954-A1 NOVEL MODULATORS OF THE SIGMA-2 RECEPTOR AND THEIR METHOD OF USE TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2024-09-12 — — US disclosed
US-11820774-B2 Modulators of the sigma-2 receptor and their method of use Temple University—Of the Commonwealth System of Higher Education (US) 2023-11-21 — — US disclosed
US-20210363145-A1 NOVEL MODULATORS OF THE SIGMA-2 RECEPTOR AND THEIR METHOD OF USE TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2021-11-25 — — US disclosed
US-10961249-B2 Modulators of the sigma-2 receptor and their method of use TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2021-03-30 — — US disclosed
US-20200039985-A1 NOVEL MODULATORS OF THE SIGMA-2 RECEPTOR AND THEIR METHOD OF USE TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2020-02-06 — — US disclosed
EP-3600290-A1 NOVEL MODULATORS OF THE SIGMA-2 RECEPTOR AND THEIR METHOD OF USE Temple University - Of The Commonwealth System of Higher Education (US) 2020-02-05 — — EP disclosed
WO-2018175188-A1 NOVEL MODULATORS OF THE SIGMA-2 RECEPTOR AND THEIR METHOD OF USE TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2018-09-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10961249-B2 Modulators of the sigma-2 receptor and their method of use SIGMAR1, TMEM97, OPRM1 TMEM97 2/4885OPRM1 3/4885OPRL1 4/4885
US-20200039985-A1 NOVEL MODULATORS OF THE SIGMA-2 RECEPTOR AND THEIR METHOD OF USE SIGMAR1, TMEM97, OPRL1 TMEM97 2/4885OPRM1 5/4885OPRL1 3/4885
US-20210363145-A1 NOVEL MODULATORS OF THE SIGMA-2 RECEPTOR AND THEIR METHOD OF USE SIGMAR1, TMEM97, OPRL1 TMEM97 2/4885OPRM1 5/4885OPRL1 3/4885
US-11820774-B2 Modulators of the sigma-2 receptor and their method of use SIGMAR1, TMEM97, OPRM1 TMEM97 2/4885OPRM1 3/4885OPRL1 4/4885
US-20240300954-A1 NOVEL MODULATORS OF THE SIGMA-2 RECEPTOR AND THEIR METHOD OF USE SIGMAR1, TMEM97, OPRL1 TMEM97 2/4885OPRM1 5/4885OPRL1 3/4885
US-12577251-B2 Modulators of the sigma-2 receptor and their method of use SIGMAR1, CHRNA6, NR3C2 TMEM97 13/4885OPRM1 28/4885OPRL1 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback